被 发 现 含 有 未 标 示 西 药 的 产 品
|
| |
| The United States: WILDMAN may be harmful due to hidden drug ingredients (English only) |
| |
The United States Food and Drug Administration (FDA) is advising consumers not to purchase or use WILDMAN, a product promoted and sold for sexual enhancement on various websites, including www.loveproducts.net, and possibly in some retail stores.
FDA laboratory analysis confirmed that WILDMAN contains sildenafil, tadalafil, sibutramine, desmethyl sibutramine and phenolphthalein not listed on the product label.
Sildenafil and tadalafil are the active ingredients in the FDA-approved prescription drugs Viagra and Cialis, respectively, used to treat erectile dysfunction. FDA approval of Viagra and Cialis is restricted to use under the supervision of a licensed health care professional. These undeclared ingredients may interact with nitrates found in some prescription drugs, such as nitroglycerin, and may lower blood pressure to dangerous levels. People with diabetes, high blood pressure, high cholesterol, or heart disease often take nitrates.
Sibutramine is a controlled substance that was removed from the market in October 2010 for safety reasons. Desmethyl sibutramine is a substance structurally similar to sibutramine. This product poses a threat to consumers because sibutramine is known to substantially increase blood pressure and/or heart rate in some people and may present a significant risk for people with a history of coronary artery disease, congestive heart failure, arrhythmias or stroke. This product may also interact, in life-threatening ways, with other medications a consumer may be taking.
Phenolphthalein is a chemical that is not an active ingredient in any approved drug in the United States. Studies have indicated that it may increase the risk of cancer.
Please refer to the following website in FDA for details:
http://www.fda.gov/drugs/medication-health-fraud/wildman-may-be-harmful-due-hidden-drug-ingredients
In Hong Kong, the above product is not a registered pharmaceutical product.
Ends/Friday, Dec 20, 2024
Issued at HKT 17:30
|
| |
